Pirtobrutinib Products | Cleanchem - Pirtobrutinib is a Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of certain cancers, such as mantle cell lymphoma. It works by selectively inhibiting BTK, an enzyme that plays a role in the survival and proliferation of cancerous B cells. This inhibition disrupts cancer cell signaling, leading to their death.

Pirtobrutinib

Cat. No: CL-PTBT-01

CAS No: 2101700-15-4

Mol. F: C22H21F4N5O3

Mol. Wt: 479.4

Inv. Status: Custom Synthesis

(R)-Pirtobrutinib

Cat. No: CL-PTBT-02

CAS No: 2101700-14-3

Mol. F: C22H21F4N5O

Mol. Wt: 479.4

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 1

Cat. No: CL-PTBT-03

CAS No: 1453472-99-5

Mol. F: C10H9F3N2O

Mol. Wt: 230.2

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 2

Cat. No: CL-PTBT-04

CAS No: 1571888-11-3

Mol. F: C16H14FNO4

Mol. Wt: 303.3

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 3

Cat. No: CL-PTBT-05

CAS No: 1453473-00-1

Mol. F: C10H11F3N2O

Mol. Wt: 232.2

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 4

Cat. No: CL-PTBT-06

CAS No: 2764851-28-5

Mol. F: C16H13ClFNO3

Mol. Wt: 321.7

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 5

Cat. No: CL-PTBT-07

CAS No: 2642629-19-2

Mol. F: C19H14FN3O3

Mol. Wt: 351.3

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 6

Cat. No: CL-PTBT-08

CAS No: 2764851-04-7

Mol. F: C20H16FN3O3

Mol. Wt: 365.4

Inv. Status: Custom Synthesis

Pirtobrutinib Nitrile Impurity

Cat. No: CL-PTBT-09

CAS No: 2642629-21-6

Mol. F: C22H19F4N5O2

Mol. Wt: 461.4

Inv. Status: Custom Synthesis

Racemic Pirtobrutinib

Cat. No: CL-PTBT-10

CAS No: 2101699-71-0

Mol. F: C22H21F4N5O3

Mol. Wt: 479.4

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 7

Cat. No: CL-PTBT-11

CAS No: NA

Mol. F: C22H20F4N4O4

Mol. Wt: 480.4

Inv. Status: Custom Synthesis

Pirtobrutinib Impurity 8

Cat. No: CL-PTBT-12

CAS No: 2940876-23-1

Mol. F: C3H7F3N2 : HCl

Mol. Wt: 128.1 : 36.5

Inv. Status: Custom Synthesis